Healthcare - Biotechnology - NASDAQ - US
$ 1.245
-17 %
$ 78.9 M
Market Cap
-1.28
P/E
Price Target
Average
221.29%
Revenue Forecast
Estimate
72.30%
EBIT
Estimate
1.85%
Net Income
Estimate
31.32%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cue Biopharma, Inc.
Wall Street analysts predict an average 1-year price target for CUE of $4 , with forecasts ranging from a low of $2 to a high of $6 .
CUE Lowest Price Target
Wall Street Target
2 USD
60.64%
CUE Average Price Target
Wall Street Target
4 USD
221.29%
CUE Highest Price Target
Wall Street Target
6 USD
381.93%
REVENUE FORECAST
Revenue Forecast Chart CUE
EBIT FORECAST
EBIT Forecast Chart CUE
NET INCOME FORECAST
Net Income Chart CUE